POPULATION DIFFERENCES IN OVARIAN-CANCER IN ISRAEL

被引：1

作者：

CHAITCHIK, S

RON, IG

BARAM, A

INBAR, M

机构：

[1] TEL AVIV MED CTR,DEPT ONCOL,TEL AVIV,ISRAEL

[2] TEL AVIV MED CTR,DEPT OBSTET & GYNECOL A,TEL AVIV,ISRAEL

来源：

GYNECOLOGIC ONCOLOGY | 1985年 / 21卷 / 02期

关键词：

D O I：

10.1016/0090-8258(85)90247-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：155 / 160

页数：6

共 21 条

[1] OVARIAN-CANCER .1. [J].

BARBER, HRK .

CA-A CANCER JOURNAL FOR CLINICIANS, 1979, 29 (06) :341-351

[2]

BEERAL V, 1978, LANCET, V1, P1083

[3] EPIDEMIOLOGIC PATHOLOGY OF OVARIAN CANCER [J].

BERG, JW ;

BAYLOR, SM .

HUMAN PATHOLOGY, 1973, 4 (04) :537-547

[4]

COHART EM, 1955, CANCER, V8, P34, DOI 10.1002/1097-0142(1955)8:1<34::AID-CNCR2820080104>3.0.CO

[5]

2-F

[6]

DEMOPOULOS RI, 1979, OBSTET GYNECOL, V54, P150

[7] EPITHELIAL CARCINOMA OF THE OVARY - CURRENT STRATEGIES [J].

KATZ, ME ;

SCHWARTZ, PE ;

KAPP, DS ;

LUIKART, S .

ANNALS OF INTERNAL MEDICINE, 1981, 95 (01) :98-111

[8] A VIRAL-ANTIGEN AS A MARKER FOR THE PROGNOSIS OF HUMAN-BREAST CANCER [J].

KEYDAR, I ;

SELZER, G ;

CHAITCHIK, S ;

HAREUVENI, M ;

KARBY, S ;

HIZI, A .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (12) :1321-1328

[9] RESPONSE TO 2ND LINE CHEMOTHERAPY IN OVARIAN-CANCER OF EPITHELIAL ORIGIN [J].

MENCZER, J ;

BAITNER, S ;

MODAN, M ;

CHAITCHIK, S ;

BRENNER, H .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (12) :1259-1262

[10]

MODAN B, 1981, ISRAEL J MED SCI, V17, P804

← 1 2 3 →